35 State Attorneys General Just Told the White House Not to Delay the Hemp-THC Ban. The White House Wanted To.
A November deadline to recriminalize intoxicating hemp products is now the center of a fight that runs from a Senate amendment all the way to a personal call from the President.
The federal government set a deadline months ago to ban intoxicating hemp-derived THC products — the drinks, gummies, and vapes sold at gas stations and smoke shops nationwide under a loophole in the 2018 Farm Bill — and that deadline is supposed to arrive in November. This week, the deadline nearly slipped, and then it didn’t, and the fight over why says more about where cannabinoid policy is actually headed than the ban itself does.
A ban set to take effect in three months just survived a quiet attempt to push it back — and the people who stopped that were state attorneys general, not Congress.
The Senate’s own funding bill had proposed pushing the ban’s effective date to December 11 — six extra weeks for an industry that has spent a year lobbying to keep the loophole open. Sen. Ted Budd of North Carolina filed an amendment this week to strip that delay language back out, keeping the original date intact, according to Marijuana Moment’s reporting. The White House had reportedly been pushing the opposite direction: President Trump personally called Budd to lobby against the amendment, and Vice President Vance reportedly worked Senate Republicans on the same ask. Meanwhile, a bipartisan coalition of attorneys general from 35 states and territories sent a joint letter opposing any delay — the ban would redefine hemp as containing no more than 0.3% total THC and cap finished products at 0.4 milligrams of THC per container, closing the gap that currently lets gas-station drinks and gummies carry a full recreational dose. The AGs’ argument is that unregulated intoxicating-hemp products — sold with none of the age verification, potency labeling, or dosing controls that govern licensed cannabis — are reaching minors right now, every day the loophole stays open.
That’s the actual split here, and it doesn’t run along the lines you’d guess. It isn’t prohibition versus legalization — most of the people pushing to close the hemp loophole aren’t anti-cannabis; several are the same officials overseeing their own states’ regulated marijuana markets, and their complaint is specifically that unregulated hemp THC is undercutting the products their states already require to be tested and age-gated. It’s regulated markets versus an accidental one, and for three months, an accident has been winning.
If you work with families or young people, the practical note is this: hemp-derived THC products are legally distinct from marijuana today, sold without the purchase-age enforcement most states apply to licensed cannabis, and that gap doesn’t close until November even in the best case for the ban’s supporters. Whatever your view on cannabinoid policy generally, that’s the specific thing worth flagging to a parent or a client this week — not because the drug is new, but because the loophole selling it to them without an ID check is.
Sources Cited
- 01.BSenators Step Up Push For Hemp THC Ban In NovemberMarijuana Moment
- 02.B
- 03.B35 Attorneys General Tell Congress to Keep Hemp THC Ban PutCannabis Business Times
Filed Under
policytrends
Keep up with the reporting.
One email each morning with the stories that put days like this in context.
Continue reading
More from this section
Insurers Got a Year and a Half of Breathing Room on the Law That's Supposed to Cover Your Treatment
The Departments of Labor, HHS, and Treasury paused enforcement of the 2024 Mental Health Parity Final Rule while litigation plays out — leaving insurers more room on prior authorization and visit limits for addiction treatment, with no enforcement deadline in sight.
Policy & FundingKratom's Civil War Just Reached a Cabinet Secretary's Investment Portfolio
The DEA placed synthetic 7-OH kratom extracts in Schedule I this week. A Senate inquiry into a cabinet secretary's stake in a rival kratom brand shows how much money is riding on where that line gets drawn — and who it leaves without a legal option.
Policy & FundingThe Global Stimulant Boom Is Hitting a Treatment System Built for Opioids
UNODC's 2026 World Drug Report found cocaine production at an all-time high and meth going industrial. The US treatment system, built around opioids, has no medication equivalent for stimulants — and hobbles the one behavioral treatment that works.